Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

375
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
375
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Multiple Allele Traits01:49

Multiple Allele Traits

37.9K
The Concept of Multiple Allelism
37.9K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

194
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
194
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

386
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
386

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Bayesian framework for longitudinal EHR and genetic discovery.

Nature·2026
Same author

ECG-Based Deep Learning to Predict Incident Atrial Fibrillation Burden.

Journal of the American Heart Association·2026
Same author

The association of eicosanoids with lung structure and function: Findings from the Multi-Ethnic Study of Atherosclerosis lung study and Framingham Heart Study.

PloS one·2026
Same author

An integrated cell atlas of 2.4 million cardiac cells across 209 individuals in health and disease.

Nature cardiovascular research·2026
Same author

Perspectives on phenotype in genetic testing for early-onset atrial fibrillation.

European journal of human genetics : EJHG·2026
Same author

Long-term Penetrance of Disease Variants in Genes Prioritized for Genomic Newborn Screening: Evidence from Adult Biobanks.

medRxiv : the preprint server for health sciences·2026

相关实验视频

Updated: Jan 8, 2026

Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

3.2K

多路线分析确定与大动脉功能和大动脉狭窄风险相关的遗传变异.

Shinwan Kany1,2,3,4, Joel T Rämö1,5,6, Cody Hou1,7

  • 1Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Nature genetics
|December 19, 2025
PubMed
概括

遗传因素影响大动脉膜功能和大动脉狭窄风险. 这项研究确定了166个基因位置,并证实了PCSK9和LDLR的作用,表明了预防大动脉狭窄的潜在治疗点.

更多相关视频

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

1.5K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.6K

相关实验视频

Last Updated: Jan 8, 2026

Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

3.2K
A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury
07:10

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

1.5K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.6K

科学领域:

  • 心血管遗传学 心血管遗传学
  • 医疗成像医学成像
  • 基因组学就是基因组学.

背景情况:

  • 遗传因素显著影响大动脉膜正常功能和发展大动脉狭窄症的风险.
  • 了解这些遗传影响对于识别早期疾病机制和潜在的预防策略至关重要.

研究的目的:

  • 研究大动脉功能的遗传结构及其与大动脉狭窄风险的关系.
  • 识别与大动脉特征和大动脉狭窄相关的新型遗传位置.
  • 探索特定脂蛋白在主动脉功能中的因果作用.

主要方法:

  • 利用深度学习进行定量磁共振成像测量大动脉功能 (峰值速度,平均梯度,大动脉面积).
  • 在一个大型队列中进行了全基因组关联研究 (GWAS) (英国生物库,n=59,571).
  • 采用GWAS的多特征分析 (MTAG) 来整合大动脉特征和大动脉狭窄GWAS数据,以及孟德尔随机化来评估因果关系.

主要成果:

  • 确定了166个与大动脉功能和/或大动脉狭窄相关的独特遗传位置,包括已知的基因PCSK9和LDLR.
  • 开发了一种对大动脉狭窄的多基因评分 (PGS),该评分显示在独立队列中与疾病风险有显著关联 (我们所有人,Mass General Brigham Biobank).
  • 门德尔随机化提供了证据,表明脂蛋白 (Lp) 和低密度脂蛋白 (LDL) 在大动脉功能中的潜在因果作用.

结论:

  • 遗传变异在大动脉功能和倾向于大动脉狭窄症方面发挥着重要作用.
  • 已确定的遗传位置和途径为大动脉狭窄的早期病原体提供了洞察力.
  • 像Lp (a) 和LDL这样的脂蛋白可能是因果因素,这表明旨在修改这些途径的预防疗法的潜在目标.